Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome

Eur J Cancer. 2013 Apr;49(6):1324-34. doi: 10.1016/j.ejca.2012.12.008. Epub 2013 Jan 10.

Abstract

Purpose: Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described.

Patients and methods: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009.

Results: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade>III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p=0.02), have frequent lymph node involvement (p=0.009) and are more often unresectable (p=0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n=4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n=10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively.

Conclusion: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chemotherapy, Adjuvant
  • Child
  • Chromogranins / metabolism
  • Combined Modality Therapy
  • Esthesioneuroblastoma, Olfactory / pathology*
  • Esthesioneuroblastoma, Olfactory / surgery
  • Esthesioneuroblastoma, Olfactory / therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nasal Cavity / metabolism
  • Nasal Cavity / pathology*
  • Neoplasm Grading
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Nose Neoplasms / pathology*
  • Nose Neoplasms / surgery
  • Nose Neoplasms / therapy
  • Prognosis
  • Radiotherapy, Adjuvant
  • Synaptophysin / metabolism
  • Treatment Outcome

Substances

  • Chromogranins
  • Synaptophysin